Thomas H. Lee (THL) Partners’s Syneos Health, Inc. Class A Common Stock SYNH Stock Holding History

Thomas H. Lee (THL) Partners’s Portfolio SYNH Stock Details SYNH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q2	–	Sell	-9,108,713	Closed	-$691M	–	3
2021 Q1	$691M	Sell	9,108,713 -4,129,829	-31%	-$311M	21.84%	2
2020 Q4	$902M	Sell	13,238,542 -2,771,759	-17%	-$173M	25.87%	2
2020 Q3	$851M	Sell	16,010,301 -3,233,719	-17%	-$193M	24.21%	2
2020 Q2	$1.12B	Hold	19,244,020	–	–	66.27%	1
2020 Q1	$759M	Hold	19,244,020	–	–	55%	1
2019 Q4	$1.14B	Hold	19,244,020	–	–	47.44%	2
2019 Q3	$1.02B	Hold	19,244,020	–	–	41.05%	2
2019 Q2	$983M	Buy	19,244,020 +31,017	+0.2%	+$1.44M	29.2%	2
2019 Q1	$994M	Hold	19,213,003	–	–	26.14%	2
2018 Q4	$756M	Buy	19,213,003 +4,356	+0%	+$202K	23.1%	2
2018 Q3	$990M	Sell	19,208,647 -5,966,191	-24%	-$292M	21.9%	2
2018 Q2	$1.18B	Hold	25,174,838	–	–	26.83%	2
2018 Q1	$894M	Hold	25,174,838	–	–	30.56%	2
2017 Q4	$1.1B	Hold	25,174,838	–	–	27.66%	2
2017 Q3	$1.32B	Buy	+25,174,838	New	+$1.4B	26.54%	2

Other funds holding SYNH

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Mackenzie Financial Toronto Ontario, Ontario, Canada $100B AUM 36.93% 1-Year Est. Return

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Cooke & Bieler Philadelphia, Pennsylvania $8.65B AUM 9.66% 1-Year Est. Return

Thomas H. Lee (THL) Partners's SYNH Position: Q2 2021 in Review

Thomas H. Lee (THL) Partners sold out of Syneos Health, Inc. Class A Common Stock (SYNH) in Q2 2021, closing a stake of 9,108,713 shares — an estimated $691M sold.

Thomas H. Lee (THL) Partners first reported a position in SYNH in Q3 2017 and held it in 15 quarters. The position peaked at $1.32B in Q3 2017. 342 funds tracked by Wall St. Rank hold SYNH as of Q2 2021.

Thomas H. Lee (THL) Partners reported no remaining Syneos Health, Inc. Class A Common Stock position as of Q2 2021 after selling out during the quarter.
Thomas H. Lee (THL) Partners sold 9,108,713 Syneos Health, Inc. Class A Common Stock shares in Q2 2021, an estimated $691M.
Thomas H. Lee (THL) Partners first reported a position in Syneos Health, Inc. Class A Common Stock in Q3 2017 and held it in 15 quarters.
Thomas H. Lee (THL) Partners's Syneos Health, Inc. Class A Common Stock position peaked at $1.32B in Q3 2017.
342 funds tracked by Wall St. Rank held Syneos Health, Inc. Class A Common Stock as of Q2 2021.

Based on Thomas H. Lee (THL) Partners's 13F filing for Q2 2021, filed 7 Oct 2021.